(2024) 17(6):e015490
The US Food and Drug Administration (FDA) has approved Wegovy to: Reduce body weight and support long-term weight loss in people with obesity or with overweight and a weight-related health condition, such as type 2 diabetes or sleep apnea Reduce the risk of experiencing a major cardiovascular event , such as heart attack, stroke, or death, in people with heart disease and obesity or overweight Typically, healthcare providers prescribe a starting dose of 0.25 mg weekly
Because it influences so many fundamental biological pathways, its introduction into a system that is already compromised can have significant, sometimes catastrophic, consequences
Flexible, breathable and dermatologically tested to stay put through showers, workouts, sleep and everyday life
Efectos secundarios y contraindicaciones de la L-Carnitina Al ser un componente naturalmente presente en el organismo, la L Carnitina es un compuesto seguro